GENE ONLINE|News &
Opinion
Blog

Licensing
Licensing Merck
Kelun Pharmaceuticals to Receive Up To $1.4 Billion From Merck in Lowkey Deal
2022-05-19
Licensing Autoimmune Disease
AbbVie & Cugene Join Forces to Tackle Autoimmune Diseases
2022-05-17
Licensing Asia
Shionogi, F2G Inks $480 Million Pact to Market Oral Antifungal in Europe and Asia
2022-05-17
Licensing Sanofi
Emerging NY Biotech Furthers Sanofi’s CNS Therapeutics
2022-04-22
Terran Biosciences announces licensing deal with Columbia University for exclusive worldwide rights to proprietary CNS biomarker software platform
2022-03-16
Licensing NFT
Genetically-Encoded NFTs May Become A Real Thing
2022-03-09
Licensing Gene Therapy
Novartis Bets $1.5 Billion on Voyager’s AAVs
2022-03-09
China Cancer
Helsinn Group Gains Marketing Rights to BridgeBio’s Truseltiq in the US
2022-03-04
Licensing COVID-19
Novartis and Molecular Partners Finalize $230 Million Pact for New Class of COVID-19 Antivirals
2022-01-19
Licensing Rare Disease
Takeda Collaborates with Immusoft to Advance Treatments in Rare Metabolic Diseases
2022-01-14
Asia-Pacific Sanofi
Sanofi Licenses ABL Bio’s Bispecific Antibody for Parkinson’s Disease
2022-01-13
China China
Grand Pharma Inks $590+ Million Deal for China Rights to ITM’s Precision Radiopharmaceuticals
2021-12-28
Licensing Immuno-oncologyNovartis
Novartis Licenses BeiGene’s Antibody for a Potential $2.8 Billion After Its Own Drug Disappoints
2021-12-21
Licensing Cancer Vaccine
In a Blockbuster Day, Vaccibody Gets New Name and a Multi-Program Regeneron Deal to Boot
2021-11-24
Licensing mRNA Technology
Sanofi Bets on Baidu’s Algorithm to Develop mRNA-Based Therapeutics
2021-11-23
1 2 3 4 5 6 7
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top